The high-performance polymer maker has raised its full-year profit guidance on healthy Demand from aerospace and electronics, reviving interest in a stock that had spent years under pressure.
Victrex (LSE:VCT) has given investors something to cheer. On 9 September 2026, the FTSE 250 specialist in high-performance PEEK polymers issued a pre-close trading update raising its full-year profit before tax guidance to £45 million to £47 million, up from £42 million to £44 million previously. The shares jumped around 14.6% to 996p in morning trading, one of the best single-day moves in the stock for some time.
The company attributed the improvement to healthy momentum in the fourth quarter of its financial year, which ended on 30 September, with Revenue growth driven by better performance across key end markets. Aerospace, value-added resellers and electronics were singled out as particularly healthy, while the Asia-Pacific region made notable progress and all regions were said to be performing well.
Cost savings and portfolio changes
Alongside the firmer trading, Victrex is pressing ahead with cost reductions. The company expects annualised savings of at least £10 million from the 2027 financial year onwards, following a reduction of about 10% in headcount. It also flagged an one-off loss of around £3 million related to the divestment of Kleiss Gears, a Business that had formed part of its push into manufactured components.
Chief executive Dr James Routh said the group had maintained healthy momentum in the fourth quarter. Victrex also appointed Chris Gilbert as interim chief financial officer from 1 September, bringing experience from Elementis and Deloitte.
The company followed up later in the month with a Capital Markets event on 24 September, where it set out its growth strategy to investors. The event formed part of an effort to rebuild confidence after a prolonged period of disappointing earnings.
From laggard to recovery candidate
Victrex's share price had fallen heavily over the past several years as demand weakened in some core markets, notably consumer electronics and industrial applications, and as the company invested heavily in new capacity, including a plant in China, and in growth programmes in medical and energy that took longer than expected to deliver. Profits had fallen well below their peak.
The latest update suggests the business may be emerging from that difficult period. Patience may still be required, given the long-term nature of Victrex's growth initiatives. The company's polymers are used in demanding applications where performance matters more than price, such as aircraft components, semiconductor Manufacturing equipment, medical implants and electric vehicles, giving it pricing power when demand is healthy.
Macro and currency factors
As an exporter that manufactures mainly in the UK, Victrex is sensitive to currency movements, particularly the value of sterling against the US dollar and euro. Its performance is also closely tied to the global industrial cycle, aerospace build rates and semiconductor capital spending. Trade tariffs and Supply chain shifts remain a potential cause of Volatility for customers in its key markets.
The next catalyst for investors will be full-year results, typically published in early December, which will confirm the outturn against the upgraded guidance and provide an outlook for the 2027 financial year. Investors will be keen to see whether the fourth-quarter momentum carries into the new year and how quickly the cost savings flow through to margins.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...